文献速递骨质疏松与钙磷/甲状旁腺糖尿病肥胖与代谢综合征

GIP与GLP-1单用及联用对超重非糖尿病男性骨代谢的影响

Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

结果显示GIP和GLP-1均降低CTX,联用具有部分叠加效应,P1NP不受影响。

要点

  • GIP和GLP-1单用均显著降低骨吸收标志物CTX。
  • GIP与GLP-1联用对CTX的抑制呈部分叠加效应。
  • 各干预均未影响骨形成标志物P1NP水平。

核心结论

  • GLP-1与GIP类似,可能参与骨吸收调节,二者联用对骨吸收具有部分叠加的抑制作用。

主要发现

  • OGTT期间CTX较基线降低54±13%,而IIGI+盐水期间降低28±12%(P<0.0001)。
  • IIGI+GLP-1和IIGI+GIP期间CTX分别较基线降低65±16%和74±9%。
  • IIGI+GIP+GLP-1期间CTX较基线降低84±4%。
  • P1NP水平未受各干预措施影响。

关键数值与推荐

  • GIP输注剂量为4 pmol/kg/min,GLP-1为1 pmol/kg/min,联用时分别为4和1 pmol/kg/min。
  • OGTT采用50-g口服葡萄糖耐量试验。

临床怎么用

  • 提示GIP和GLP-1可能对骨吸收有抑制作用,联用效应更强,但需进一步研究确定临床意义。

局限性

  • 研究仅纳入超重/肥胖非糖尿病男性,结果外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The gut-derived incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) have been suggested to play a role in bone metabolism. Exogenous administration of GIP inhibits bone resorption, but the effect of GLP-1 is less clear. Furthermore, the combined effect of exogenous GIP and GLP-1 on bone metabolism is unknown. OBJECTIVE: To investigate the effect of separate and combined infusions of the incretin hormones GIP and GLP-1 on bone resorption and formation. DESIGN: Randomized, double-blinded, placebo-controlled, crossover study including five study days. PARTICIPANTS: Seventeen overweight/obese men. INTERVENTIONS: On the first study day, a 50-g oral glucose tolerance test (OGTT) was performed. On the next four study days, isoglycemic IV glucose infusions (IIGI), mimicking the glucose excursions from the OGTT, were performed with concomitant infusions of GIP (4 pmol/kg/min), GLP-1 (1 pmol/kg/min), GIP+GLP-1 (4 and 1 pmol/kg/min, respectively), or placebo, respectively. PRIMARY OUTCOMES: Changes in bone resorption assessed by measurements of carboxy-terminal type I collagen crosslinks (CTX) and in bone formation as assessed by procollagen type 1 N-terminal propeptide (P1NP) concentrations. RESULTS: During the OGTT, CTX was significantly lowered by 54 ± 13% from baseline (mean ± SD) compared with 28 ± 12% during IIGI + saline (P < 0.0001). During IIGI+GLP-1 and IIGI+GIP, CTX was lowered by 65 ± 16% and 74 ± 9%, respectively, from baseline, whereas IGII+GIP+GLP-1 lowered CTX by 84 ± 4% from baseline. P1NP levels were unaffected by the interventions. CONCLUSIONS: Our data suggest that GLP-1, like GIP, may be involved in regulation of bone resorption and that GIP and GLP-1 together have partially additive inhibitory effects.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bergmann NC, Lund A, Gasbjerg LS, et al. Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes. J Clin Endocrinol Metab. 2019. PMID: 30848791. doi:10.1210/jc.2019-00008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。